Moneycontrol PRO


Natco stirs patent battle with generic version of Sprycel

CNBC-TV18's Archana Shukla reports that the pharma sector may soon be embroiled in a patent battle over US drugmaker Bristol Myer Squibb's (BMS) USD 800-million blood-cancer drug Sprycel

first published: Jul 12, 2012 09:38 pm


Watch More →

A collection of the most-viewed Moneycontrol videos.

Watch and Follow our leading shows